Evaluating the patient-level association between progression-free survival and overall survival in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer (MSI-H/dMMR mCRC) treated with immune checkpoint inhibitors

被引：0

作者：

Roodhart, J. M. L. ^{[1
]}

Sharpe, D. J. ^{[2
]}

Tate, A. E. ^{[3
]}

Bertwistle, D. ^{[4
]}

Dixon, M. ^{[4
]}

Chen, H-H. ^{[4
]}

Kurt, M. ^{[4
]}

机构：

[1] Univ Utrecht, Univ Med Ctr Utrecht, Med Oncol Dept, Utrecht, Netherlands

[2] Parexel, Access Consulting, London, England

[3] Parexel, Access Consulting, Amsterdam, Netherlands

[4] Bristol Myers Squibb, Global HEOR, Lawrenceville, NJ USA

来源：

关键词：

D O I：

10.1016/j.annonc.2024.05.068

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

57P

引用

页码：S27 / S27

页数：1